We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.79B
AUM Growth
+$618M
Cap. Flow
+$595M
Cap. Flow %
33.32%
Top 10 Hldgs %
16.68%
Holding
4,499
New
1,229
Increased
1,153
Reduced
1,264
Closed
790

Sector Composition

Rank Sector Weight
1 Technology 13.59%
2 Financials 10.04%
3 Healthcare 8.35%
4 Industrials 7.34%
5 Consumer Discretionary 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORBK
2226
DELISTED
Orbotech Ltd
ORBK
$28K ﹤0.01%
445
+139
+45% +$8.59K
AMNB
2227
DELISTED
American National Bankshares Inc
AMNB
$28K ﹤0.01%
696
+132
+23% +$5.24K
VRML
2228
DELISTED
Vermillion, Inc.
VRML
$28K ﹤0.01%
36,044
+32,237
+847% +$36.2K
BHVN
2229
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$28K ﹤0.01%
720
-368
-34% -$11.7K
BIP icon
2230
Brookfield Infrastructure Partners
BIP
$18B
$27K ﹤0.01%
1,198
-6,176
-84% -$145K
CTBI icon
2231
Community Trust Bancorp
CTBI
$1.41B
$27K ﹤0.01%
+539
New +$26.6K
CUK
2232
DELISTED
Carnival PLC
CUK
$27K ﹤0.01%
460
-504
-52% -$32.4K
ECVT icon
2233
Ecovyst
ECVT
$1.14B
$27K ﹤0.01%
1,500
-3,057
-67% -$47.8K
JRI icon
2234
Nuveen Real Asset Income & Growth Fund
JRI
$352M
$27K ﹤0.01%
+1,689
New +$27.5K
LIT icon
2235
Global X Lithium & Battery Tech ETF
LIT
$1.6B
$27K ﹤0.01%
+836
New +$28K
MATV icon
2236
Mativ Holdings
MATV
$711M
$27K ﹤0.01%
+628
New +$26.7K
MTEX icon
2237
Mannatech
MTEX
$9.24M
$27K ﹤0.01%
+1,320
New +$25.7K
OCSL icon
2238
Oaktree Specialty Lending
OCSL
$1.14B
$27K ﹤0.01%
1,896
-2,420
-56% -$33.7K
ORA icon
2239
Ormat Technologies
ORA
$6.64B
$27K ﹤0.01%
+508
New +$27.7K
PEGA icon
2240
Pegasystems
PEGA
$5.38B
$27K ﹤0.01%
+994
New +$30.5K
PRAA icon
2241
PRA Group
PRAA
$755M
$27K ﹤0.01%
+690
New +$26.6K
RCUS icon
2242
Arcus Biosciences
RCUS
$3.64B
$27K ﹤0.01%
+2,216
New +$34.8K
RRX icon
2243
Regal Rexnord
RRX
$11.9B
$27K ﹤0.01%
333
-3,155
-90% -$244K
SGRY icon
2244
Surgery Partners
SGRY
$2.03B
$27K ﹤0.01%
+1,830
New +$30.7K
TRNS icon
2245
Transcat
TRNS
$871M
$27K ﹤0.01%
1,385
+1,259
+999% +$22.3K
TTSH
2246
DELISTED
Tile Shop Holdings
TTSH
$27K ﹤0.01%
+3,555
New +$24.6K
WSBC icon
2247
WesBanco
WSBC
$4B
$27K ﹤0.01%
+605
New +$27.4K
EGRX
2248
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$27K ﹤0.01%
362
-1,596
-82% -$100K
CORR
2249
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$27K ﹤0.01%
720
-2,464
-77% -$91.7K
SRRA
2250
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$27K ﹤0.01%
228
+131
+135% +$13.1K

Similar funds

Tower Research Capital (TRC)'s Q2 2018 Portfolio in Review

As of Q2 2018, Tower Research Capital (TRC) held 4,499 positions worth $1.79B, up 53% from $1.17B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Tower Research Capital (TRC) deployed $595M of net new capital in Q2 2018, opening 1,229 new positions and adding to 1,153 existing holdings. Its largest new stake was JPMorgan Chase: 180,678 shares worth $18.8M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 4.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $31.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2018 buy was JPMorgan Chase: 180,678 shares worth $18.8M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2018, an estimated $51.7M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2018 reduction was iShares MSCI EAFE ETF, cutting an estimated $31.8M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Dow Jones REIT ETF in Q2 2018, selling an estimated $6.85M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 17% of its $1.79B portfolio in Q2 2018.
  • Tower Research Capital (TRC) opened 1,229 new positions and closed 790 in Q2 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 53% quarter-over-quarter to $1.79B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2018, filed 15 Aug 2018.